Imo Pharmacists Decry Neglect By Uzodinma AdministrationImo Pharmacists Decry Neglect By Uzodinma Administration

The president, Pharmaceutical Society of Nigeria PSN, Professor Sam Ohuabunwa, has frowned at Governor Hope Uzodinma over what he termed his shortsightedness in assisting the efforts of some individuals in business development geared towards employment generation for the state.

Prof. Ohuabunwa, who was on an assessment tour of STK Biotech, an indigenous pharmaceutical company bases in Owerri Thursday, said he regretted that Governor Uzodinma was not present to witness the personal efforts being made by a single individual in alleviating the hardships experienced by Imo people and see how government can assist in complimenting the efforts.


“Governor Uzodinma should have been here, even the LGA chairman for Owerri North. STK has done well, and should be commended by government. At this level of development, government and big corporate organisations should be seeking for ways to assist they company hit her target,” he lamented.

He commended the management of the company for their efforts in tackling the health challenges facing the country through the provisions of affordable and quality drugs.



Prof. Ohuabunwa, who was the former Managing Director of Pfizer Pharmaceuticals West African, now Niemeth Pharmaceuticals, however, encouraged STK Biotech management to focus attention on marketing their products, saying every good product cannot be seen unless it becomes public.

While making a presentation, Prof. Kenneth Anchang Yongabi, a professor of public health infectiology and phytobiotechnology, Imo state University Owerri said STK started about eleven years ago.

“We are an innovative biotech company that bridges the gap between research and production.

“We also provides a holistic environment where traditional, complementary, alternative and orthodox medicine can be found seamlessly deployed side by side” he explained.

Speaking further prof. Yongabi who incidentally is the co-founder of STK Biotech said currently, Novartis pharmaceutical based in USA has given them an appointment letter, to work with them on science based research. He outlined some of their products to include; STK Boosters, STK Hepatozone, STK Phytomune, STK Loose-IT, STK Skan and STK REV.

#orientdailynews